AI Summary & Key Takeaways
AI InsightOn a long-term basis, the re-ischemia-free survival was nearly twice as high as inprevious studies that reported more cases treated by rotational percutaneous mechanicalthrombectomy alone.CONCLUSIONTo assure a long-lasting primary patency after percutaneous mechanical thrombectomy,concomitant treatment of underlying lesions with adjunctive, nonthrombolytic endovascularmethods should be considered
📌 3 Key Takeaways
Özet
PURPOSEWe aimed to evaluate the role of adjunctive, solely nonthrombolytic endovascular therapy intreatment of acute lower-extremity ischemia by rotational percutaneous mechanical thrombectomy.METHODSA retrospective, single-center evaluation of 165 patients (167 limbs) that underwent rotational percutaneous mechanical thrombectomy between 2009 and 2016 was performed.RESULTSRotational percutaneous mechanical thrombectomy was used as a single therapy in 9.0% (15limbs), followed by percutaneous aspiration thrombectomy in 6.0% (10 limbs), percutaneoustransluminal angioplasty in 19.8% (33 limbs) and stenting in 25.7% (43 limbs). Rotational percutaneous mechanical thrombectomy was followed by any combination of these three interventions in 39.5%. Clinical and technical success was documented in 92.2%, complications in10.3% (n=17). No significant difference in clinical and technical success was observed usingrotational percutaneous mechanical thrombectomy alone or with additional endovasculartherapy. On a long-term basis, the re-ischemia-free survival was nearly twice as high as inprevious studies that reported more cases treated by rotational percutaneous mechanicalthrombectomy alone.CONCLUSIONTo assure a long-lasting primary patency after percutaneous mechanical thrombectomy,concomitant treatment of underlying lesions with adjunctive, nonthrombolytic endovascularmethods should be considered